Affordable Access

deepdyve-link
Publisher Website

Low-volume insulin degludec 200 units/ml once daily improves glycemic control similarly to insulin glargine with a low risk of hypoglycemia in insulin-naive patients with type 2 diabetes: a 26-week, randomized, controlled, multinational, treat-to-target trial: the BEGIN LOW VOLUME trial.

Authors
  • Gough, Stephen C L
  • Bhargava, Anuj
  • Jain, Rajeev
  • Mersebach, Henriette
  • Rasmussen, Søren
  • Bergenstal, Richard M
Type
Published Article
Journal
Diabetes Care
Publisher
American Diabetes Association
Publication Date
Sep 01, 2013
Volume
36
Issue
9
Pages
2536–2542
Identifiers
DOI: 10.2337/dc12-2329
PMID: 23715753
Source
Medline
License
Unknown

Abstract

In this treat-to-target trial in insulin-naïve patients with T2DM, IDeg 200 units/mL improved glycemic control similarly to IGlar with a low risk of hypoglycemia.

Report this publication

Statistics

Seen <100 times